Diabetes epidemiology in the covid-19 pandemic

Elizabeth Selvin; Stephen P. Juraschek

doi:10.2337/dc20-1295

Diabetes epidemiology in the covid-19 pandemic

Elizabeth Selvin, Stephen P. Juraschek

Bloomberg School of Public Health

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Abstract

Diabetes has been identified as an important risk factor for mortality and rates of progression to acute respiratory distress syndrome (ARDS) in hospitalized patients with coronavirus disease 2019 (COVID-19). However, many recent reports on this topic reflect hurried approaches and have lacked careful epidemiologic design, conduct, and analysis. Features of prior studies have posed problems for our understanding of the true contribution of diabetes and other underlying comor-bidities to prognosis in COVID-19. In this Perspective, we discuss some of the challenges of interpreting the current literature on diabetes and COVID-19 and discuss opportunities for future epidemiologic studies. We contend that the COVID-19 pandemic is a defining moment for the field of epidemiology and that diabetes epidemiology should play a significant role.

Original language	English (US)
Pages (from-to)	1690-1694
Number of pages	5
Journal	Diabetes care
Volume	43
Issue number	8
DOIs	https://doi.org/10.2337/dc20-1295
State	Published - Aug 2020

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Advanced and Specialized Nursing

Access to Document

10.2337/dc20-1295

Cite this

@article{24f77e928dfd46a0a4000d3239ab9aa4,

title = "Diabetes epidemiology in the covid-19 pandemic",

abstract = "Diabetes has been identified as an important risk factor for mortality and rates of progression to acute respiratory distress syndrome (ARDS) in hospitalized patients with coronavirus disease 2019 (COVID-19). However, many recent reports on this topic reflect hurried approaches and have lacked careful epidemiologic design, conduct, and analysis. Features of prior studies have posed problems for our understanding of the true contribution of diabetes and other underlying comor-bidities to prognosis in COVID-19. In this Perspective, we discuss some of the challenges of interpreting the current literature on diabetes and COVID-19 and discuss opportunities for future epidemiologic studies. We contend that the COVID-19 pandemic is a defining moment for the field of epidemiology and that diabetes epidemiology should play a significant role.",

author = "Elizabeth Selvin and Juraschek, {Stephen P.}",

note = "Funding Information: Funding. E.S. was supported by National Institutes of Health National Heart, Lung, and Blood Institute grant K24 HL152440. Duality of Interest. No potential conflicts of interest relevant to this article were reported. Funding Information: E.S. was supported by National Institutes of Health National Heart, Lung, and Blood Institute grant K24 HL152440. Publisher Copyright: {\textcopyright} 2020 by the American Diabetes Association.",

year = "2020",

month = aug,

doi = "10.2337/dc20-1295",

language = "English (US)",

volume = "43",

pages = "1690--1694",

journal = "Diabetes care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "8",

}

TY - JOUR

T1 - Diabetes epidemiology in the covid-19 pandemic

AU - Selvin, Elizabeth

AU - Juraschek, Stephen P.

N1 - Funding Information: Funding. E.S. was supported by National Institutes of Health National Heart, Lung, and Blood Institute grant K24 HL152440. Duality of Interest. No potential conflicts of interest relevant to this article were reported. Funding Information: E.S. was supported by National Institutes of Health National Heart, Lung, and Blood Institute grant K24 HL152440. Publisher Copyright: © 2020 by the American Diabetes Association.

PY - 2020/8

Y1 - 2020/8

N2 - Diabetes has been identified as an important risk factor for mortality and rates of progression to acute respiratory distress syndrome (ARDS) in hospitalized patients with coronavirus disease 2019 (COVID-19). However, many recent reports on this topic reflect hurried approaches and have lacked careful epidemiologic design, conduct, and analysis. Features of prior studies have posed problems for our understanding of the true contribution of diabetes and other underlying comor-bidities to prognosis in COVID-19. In this Perspective, we discuss some of the challenges of interpreting the current literature on diabetes and COVID-19 and discuss opportunities for future epidemiologic studies. We contend that the COVID-19 pandemic is a defining moment for the field of epidemiology and that diabetes epidemiology should play a significant role.

AB - Diabetes has been identified as an important risk factor for mortality and rates of progression to acute respiratory distress syndrome (ARDS) in hospitalized patients with coronavirus disease 2019 (COVID-19). However, many recent reports on this topic reflect hurried approaches and have lacked careful epidemiologic design, conduct, and analysis. Features of prior studies have posed problems for our understanding of the true contribution of diabetes and other underlying comor-bidities to prognosis in COVID-19. In this Perspective, we discuss some of the challenges of interpreting the current literature on diabetes and COVID-19 and discuss opportunities for future epidemiologic studies. We contend that the COVID-19 pandemic is a defining moment for the field of epidemiology and that diabetes epidemiology should play a significant role.

UR - http://www.scopus.com/inward/record.url?scp=85088274336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85088274336&partnerID=8YFLogxK

U2 - 10.2337/dc20-1295

DO - 10.2337/dc20-1295

M3 - Article

C2 - 32540920

AN - SCOPUS:85088274336

SN - 0149-5992

VL - 43

SP - 1690

EP - 1694

JO - Diabetes care

JF - Diabetes care

IS - 8

ER -

Diabetes epidemiology in the covid-19 pandemic

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this